Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;42(4):337-342.
doi: 10.4103/lungindia.lungindia_630_24. Epub 2025 Jun 27.

Eosinophil count and treatment response in COPD patients

C R Kiran  1 , K Anitha Kumari  2 , Sanjeev Nair  1 , A Fathahudeen  1
Affiliations

Eosinophil count and treatment response in COPD patients

C R Kiran et al. Lung India. .

Abstract

Background and objective: Eosinophils are an integral part of lung defence against microbes. It is also responsible for untoward hyper immune responses responsible for lung diseases including Chronic Obstructive Pulmonary Disease (COPD). To compare COPD patients with high and low Absolute Eosinophil Count (AEC) regarding their frequency of exacerbations, and response to treatment.

Materials and methods: Prospective observational study. Patients were divided into 2 groups above and below the mean AEC and followed up for 6 months, during when their frequencies of exacerbations were followed up. At the end of 6 months, symptomatology and lung function were reassessed.

Results: Those with high AEC had a shorter time to first exacerbation. These patients also needed significantly greater number of inpatient admissions during the study period. Fall in FEV1 was also significantly higher in this group. There was no significant difference in changes in BMI, CAT or MMRC scores, between these groups.

Conclusion: Patients with high AEC are at higher risk of exacerbations, as well as loss of lung function.

Keywords: COPD; disease exacerbations; eosinophils.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interests

Figures

Figure 1
Figure 1
(a) Change in FEV1 compared with AEC, (b) Change in BMI compared with AEC, (c) Change in CAT score compared with AEC
See this image and copyright information in PMC

References

    1. 2024 GOLD Report - Global Initiative for Chronic Obstructive Lung Disease - GOLD. Available from: https://goldcopd.org/2024-gold-report/ . [Last accessed on 2024 Nov 09]
    1. Oliver B, Tonga K, Darley D, Rutting S, Zhang X, Chen H, et al. COPD treatment choices based on blood eosinophils: Are we there yet? Breathe (Sheff) 2019;15:318–23. - PMC - PubMed
    1. GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf [Internet] Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14N... . [Last accessed on 2025 May 29]
    1. Kiran CR, Kumari AK, Nair S, George TP. Eosinophil count in COPD-Do we need different cut-offs for our population? Pulmon. 2021;23:151–6.
    1. David B, Bafadhel M, Koenderman L, De Soyza A. Eosinophilic inflammation in COPD: From an inflammatory marker to a treatable trait. Thorax. 2021;76:188–95. - PMC - PubMed

LinkOut - more resources